Search for other papers by Cosimo Rodia in
Google Scholar
PubMed
Search for other papers by Francesca Menconi in
Google Scholar
PubMed
Search for other papers by Laura Mazoni in
Google Scholar
PubMed
Search for other papers by Liborio Torregrossa in
Google Scholar
PubMed
Search for other papers by Fulvio Basolo in
Google Scholar
PubMed
Search for other papers by Paolo Vitti in
Google Scholar
PubMed
Search for other papers by Claudio Marcocci in
Google Scholar
PubMed
Search for other papers by Michele Marinò in
Google Scholar
PubMed
What Is Known about this Topic? Thyroid dermopathy is a rare extrathyroidal manifestation of Graves’ disease (GD). It is usually bilateral, but monolateral variants can be observed. As for Graves’ orbitopathy, the most common
Search for other papers by Marta Amaro da Silveira Duval in
Google Scholar
PubMed
Search for other papers by André Borsatto Zanella in
Google Scholar
PubMed
Search for other papers by Ana Patrícia Cristo in
Google Scholar
PubMed
Search for other papers by Carlo Sasso Faccin in
Google Scholar
PubMed
Search for other papers by Marcia Silva Graudenz in
Google Scholar
PubMed
Search for other papers by Ana Luiza Maia in
Google Scholar
PubMed
Introduction Differentiated thyroid cancer (DTC) is the most common endocrine cancer, accounting for approximately 90% of the thyroid gland malignancies [ 1 ]. DTC prevalence has risen in the last decades, mainly due to the papillary subtype
Search for other papers by Eddy Rijntjes in
Google Scholar
PubMed
Search for other papers by Philip Moritz Scholz in
Google Scholar
PubMed
Search for other papers by Govindasamy Mugesh in
Google Scholar
PubMed
Search for other papers by Josef Köhrle in
Google Scholar
PubMed
Introduction The thioamide compounds 6- n -propyl-2-thiouracil (PTU), methimazole (MMI) and carbimazole represent widely used anti-thyroid therapeutic drugs in the treatment of hyperthyroidism [ 1 ]. Their main pharmacological target is the
INSERM 1086 ANTICIPE, Caen University, Caen, France
Search for other papers by Renaud Ciappuccini in
Google Scholar
PubMed
Search for other papers by Virginie Saguet-Rysanek in
Google Scholar
PubMed
Search for other papers by Marine Dorbeau in
Google Scholar
PubMed
Search for other papers by Justine Lequesne in
Google Scholar
PubMed
Search for other papers by Camille Linard in
Google Scholar
PubMed
Search for other papers by Sophie Lefevre-Arbogast in
Google Scholar
PubMed
Search for other papers by Bénédicte Clarisse in
Google Scholar
PubMed
Search for other papers by Stéphane Bardet in
Google Scholar
PubMed
thyroid nodules with indeterminate cytology, enabling malignancy in 18 FCH-negative nodules to be reliably excluded ( 3 ). Some cases of increased and diffuse 18 FCH uptake in the thyroid gland have been described in the imaging workup of patients with
College of Medicine, Yonsei University, Seoul, Republic of Korea
Search for other papers by Jihwan Yoo in
Google Scholar
PubMed
Search for other papers by Hee Jun Kim in
Google Scholar
PubMed
Search for other papers by Seok Mo Kim in
Google Scholar
PubMed
Search for other papers by Hun Ho Park in
Google Scholar
PubMed
Introduction Patients with differentiated thyroid cancer (DTC) generally have a good prognosis, even in cases of stage IV disease. The 10-year disease-specific survival rate is 82.6%, which is longer than that among patients with other
Project Chernobyl, Brooklyn, New York, USA
Search for other papers by Valentina M. Drozd in
Google Scholar
PubMed
Search for other papers by Igor Branovan in
Google Scholar
PubMed
Search for other papers by Nikolay Shiglik in
Google Scholar
PubMed
Search for other papers by Johannes Biko in
Google Scholar
PubMed
Clinic and Polyclinic of Nuclear Medicine, University of Würzburg, Würzburg, Germany
Search for other papers by Christoph Reiners in
Google Scholar
PubMed
Introduction During the last 30 years, the incidence of differentiated thyroid cancer (DTC) has steadily increased worldwide, most markedly in France, Italy, the Republic of Korea, Australia, and the USA [ 1 - 8 ]. In the USA, DTC incidence is
Search for other papers by George J. Kahaly in
Google Scholar
PubMed
Search for other papers by Luigi Bartalena in
Google Scholar
PubMed
Search for other papers by Lazlo Hegedüs in
Google Scholar
PubMed
Search for other papers by Laurence Leenhardt in
Google Scholar
PubMed
Search for other papers by Kris Poppe in
Google Scholar
PubMed
Search for other papers by Simon H. Pearce in
Google Scholar
PubMed
Epidemiology and Pathogenesis Hyperthyroidism occurs due to an inappropriately high synthesis and secretion of thyroid hormone (TH) by the thyroid [ 1 ]. TH increases tissue thermogenesis and the basal metabolic rate, and reduces serum
Search for other papers by Shinsuke Shinkai in
Google Scholar
PubMed
Medical Education Center, Hamamatsu University School of Medicine, Shizuoka, Japan
Search for other papers by Kenji Ohba in
Google Scholar
PubMed
Search for other papers by Kennichi Kakudo in
Google Scholar
PubMed
Search for other papers by Takayuki Iwaki in
Google Scholar
PubMed
Search for other papers by Yoshihiro Mimura in
Google Scholar
PubMed
Search for other papers by Akio Matsushita in
Google Scholar
PubMed
Search for other papers by Go Kuroda in
Google Scholar
PubMed
Search for other papers by Yuki Sakai in
Google Scholar
PubMed
Search for other papers by Nobuhiko Nishino in
Google Scholar
PubMed
Department of Pharmacology, Hamamatsu University School of Medicine, Shizuoka, Japan
Search for other papers by Kazuo Umemura in
Google Scholar
PubMed
Search for other papers by Takafumi Suda in
Google Scholar
PubMed
Search for other papers by Shigekazu Sasaki in
Google Scholar
PubMed
What Is Known about This Topic? • Hyperfunctioning thyroid carcinoma is rare, and its molecular etiology is not clear. • To the best of our knowledge, there is no reported case of hyperfunctioning thyroid carcinoma with a BRAF mutation (a
Search for other papers by John Lazarus in
Google Scholar
PubMed
Search for other papers by Rosalind S. Brown in
Google Scholar
PubMed
Search for other papers by Chantal Daumerie in
Google Scholar
PubMed
Search for other papers by Alicja Hubalewska-Dydejczyk in
Google Scholar
PubMed
Search for other papers by Roberto Negro in
Google Scholar
PubMed
Search for other papers by Bijay Vaidya in
Google Scholar
PubMed
Introduction Subclinical hypothyroidism (SCH) in pregnancy is defined by a serum thyroid-stimulating hormone (TSH) concentration higher than the upper limit of the pregnancy-related reference range associated with a normal serum thyroxine [T 4
Thyroid Head and Neck Ablation Center, Kaohsiung Chang Gung Memorial Hospital, Taiwan
Search for other papers by Pi-Ling Chiang in
Google Scholar
PubMed
Department of Otolaryngology, Kaohsiung Chang Gung Memorial Hospital, and Chang Gung University College of Medicine, Kaohsiung, Taiwan
Search for other papers by Sheng-Dean Luo in
Google Scholar
PubMed
Department of Nuclear Medicine, Kaohsiung Chang Gung Memorial Hospital, and Chang Gung University College of Medicine, Kaohsiung, Taiwan
Search for other papers by Yen-Hsiang Chang in
Google Scholar
PubMed
Division of Endocrinology and Metabolism, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital, and Chang Gung University College of Medicine, Kaohsiung, Taiwan
Search for other papers by Chen-Kai Chou in
Google Scholar
PubMed
Departments of Surgery, Kaohsiung Chang Gung Memorial Hospital, and Chang Gung University College of Medicine, Kaohsiung, Taiwan
Search for other papers by Shun-Yu Chi in
Google Scholar
PubMed
Thyroid Head and Neck Ablation Center, Kaohsiung Chang Gung Memorial Hospital, Taiwan
Search for other papers by Yi-Fan Chen in
Google Scholar
PubMed
Thyroid Head and Neck Ablation Center, Kaohsiung Chang Gung Memorial Hospital, Taiwan
Department of Radiology, Jen-Ai Hospital, Dali Branch, Taichung, Taiwan
School of Medicine, College of Medicine, National Sun Yat-Sen University, Kaohsiung City, Taiwan
Search for other papers by Wei-Che Lin in
Google Scholar
PubMed
Introduction Thyroid nodules are a common and usually benign occurrence. Previous studies have reported prevalence rates of 2–6% with palpation, and 19–35% with ultrasound ( 1 ). With the current widespread use of ultrasound in clinical